Patent 10557119 was granted and assigned to Rubius Therapeutics on February, 2020 by the United States Patent and Trademark Office.
Compositions comprising synthetic membrane-receiver complexes, methods of generating synthetic membrane-receiver complexes, and methods of treating or preventing diseases, disorders or conditions therewith.